Clearmind Medicine Inc. Stock Canadian Securities Exchange
Equities
CMND
CA1850534027
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 1.78M 2.44M |
---|---|---|---|---|---|
Net income 2022 | -9M -12.3M | Net income 2023 | -8M -10.94M | EV / Sales 2022 | - |
Net cash position 2022 | 388K 530K | Net cash position 2023 | 5.51M 7.54M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.09
x | P/E ratio 2023 |
-0.09
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |